Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease Journal Article


Authors: Keliher, E. J.; Ye, Y. X.; Wojtkiewicz, G. R.; Aguirre, A. D.; Tricot, B.; Senders, M. L.; Groenen, H.; Fay, F.; Perez-Medina, C.; Calcagno, C.; Carlucci, G.; Reiner, T.; Sun, Y.; Courties, G.; Iwamoto, Y.; Kim, H. Y.; Wang, C.; Chen, J. W.; Swirski, F. K.; Wey, H. Y.; Hooker, J.; Fayad, Z. A.; Mulder, W. J. M.; Weissleder, R.; Nahrendorf, M.
Article Title: Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease
Abstract: Tissue macrophage numbers vary during health versus disease. Abundant inflammatory macrophages destruct tissues, leading to atherosclerosis, myocardial infarction and heart failure. Emerging therapeutic options create interest in monitoring macrophages in patients. Here we describe positron emission tomography (PET) imaging with 18 F-Macroflor, a modified polyglucose nanoparticle with high avidity for macrophages. Due to its small size, Macroflor is excreted renally, a prerequisite for imaging with the isotope flourine-18. The particle's short blood half-life, measured in three species, including a primate, enables macrophage imaging in inflamed cardiovascular tissues. Macroflor enriches in cardiac and plaque macrophages, thereby increasing PET signal in murine infarcts and both mouse and rabbit atherosclerotic plaques. In PET/magnetic resonance imaging (MRI) experiments, Macroflor PET imaging detects changes in macrophage population size while molecular MRI reports on increasing or resolving inflammation. These data suggest that Macroflor PET/MRI could be a clinical tool to non-invasively monitor macrophage biology. © 2017 The Author(s).
Keywords: murinae; primates; oryctolagus cuniculus
Journal Title: Nature Communications
Volume: 8
ISSN: 2041-1723
Publisher: Nature Publishing Group  
Date Published: 2017-01-16
Start Page: 14064
Language: English
DOI: 10.1038/ncomms14064
PROVIDER: scopus
PMCID: PMC5241815
PUBMED: 28091604
DOI/URL:
Notes: Article -- Export Date: 2 February 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Thomas Reiner
    136 Reiner